A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness-Reference-Cited by-同舟云学术

A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness

Published:2013-01 Issue:1 Volume:143 Page:138-142
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Madigan Kevin,Brennan Daria,Lawlor Elizabeth,Turner Niall,Kinsella Anthony,O'Connor John J.,Russell Vincent,Waddington John L.,O'Callaghan Eadbhard

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference37 articles.

1. A depression rating scale for schizophrenics;Addington;Schizophr. Res.,1990

2. Reliability and validity of a depression rating scale for schizophrenics;Addington;Schizophr. Res.,1992

3. The Scale for Assessment of Negative Symptoms (SANS);Andreasen,1983

4. The Scale for Assessment of Positive Symptoms (SAPS);Andreasen,1984

5. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with co-morbid schizophrenia and substance use disorders;Barrowclough;Am. J. Psychiatry,2001

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychosocial Interventions for Individuals With Comorbid Psychosis and Substance Use Disorders: Systematic Review and Meta-analysis of Randomized Studies;Schizophrenia Bulletin;2024-06-28

2. Cognitive behavioural therapy added to standard care for first-episode and recent-onset psychosis;Cochrane Database of Systematic Reviews;2024-03-12

3. Predictors of relapse and engagement in care one year after ending services in an urban safety net coordinated specialty care program for first episode psychosis;Schizophrenia Research;2024-02

4. Avatar Intervention for Cannabis Use Disorder in a Patient with Schizoaffective Disorder: A Case Report;BioMedInformatics;2023-12-06

5. Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis;Journal of Child and Adolescent Psychopharmacology;2023-10-01